Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostanoid Therapy in Severe Pulmonary Arterial Hypertension - Imaging Control Study, 3D Echo, MR and RHC.

NCT02198456 is registered in ClinicalTrials.gov with Regina Steringer-Mascherbauer as lead sponsor.

NCT NCT02198456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02198456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostanoid Therapy in Severe Pulmonary Arterial Hypertension - Imaging Control Study, 3D Echo, MR and RHC.
Lead sponsor
Regina Steringer-Mascherbauer
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2014
Completion date
December 31, 2019
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension who group i